NMC.L Regulatory News (NMC)

London, 25 May 2018: NMC Health Plc ("NMC" or the "Company") (LSE:NMC), the leading United Arab Emirates private healthcare operator with international services across 13 countries, announces circulation of its Notice of 2018 Annual General Meeting and confirms details of the timetable for payment of its 2017 final dividend.

The Company's 2018 Annual General Meeting will be held on Thursday 28 June 2018, at 2:30pm at the offices of Allen & Overy LLP, One Bishops Square, London E1 6AD. A copy of the Notice of the 2018 Annual General Meeting Circular and the accompanying Form of Proxy are today being posted to shareholders and have been submitted to the National Storage Mechanism and will be available for inspection at www.Morningstar.co.uk/uk/NSM. In addition, the Circular is available to view on the Company's website http://www.nmchealth.com/shareholder-information.

Following the 2017 financial year final results announcement of the Company made on 7 March 2018, in which the Board announced that it is recommending a final dividend of 13 pence per ordinary share, the Company hereby confirms the following timetable for payment of this dividend:

· Ex-dividend date: 14 June 2018

· Record date: 15 June 2018

· Payment date: 10 July 2018 

Payment of the final dividend remains subject to shareholder approval at the Company's 2018 Annual General Meeting.

Contacts

About NMC Health plc

NMC Health plc, is the leading United Arab Emirates private healthcare operator with an international network of hospitals. The Group currently operates or manages over 125 assets across 13 countries. NMC Health plc is also ranked as one of the top 3 in-vitro fertilisation ("IVF") operators globally. The Group is also a leading provider of long-term medical care in the UAE through its subsidiary ProVita. Pursuing an aggressive international expansion program from 2016, the Company now has over 35% of its licensed bed capacity in the Kingdom of Saudi Arabia (KSA), where the Company has introduced long-term and multi-specialty care services. The enlarged Group received over 5.7m patients in 2017. The Group is also a leading UAE supplier of products and consumables across several key market segments, with the major contribution coming from healthcare related products. The Group reported revenues of USD 1.6 billion for the year ended 31 December 2017.

In April 2012 NMC Health plc was listed on the Premium Segment of the London Stock Exchange. NMC Health plc is a constituent of the FTSE 100 Index.